<HashMap><database>biostudies-arrayexpress</database><scores/><additional><submitter>Giulia Picco</submitter><organism>Mus musculus</organism><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-15596</full_dataset_link><description>Haematopoietic and endothelial cells derive from a subset of Flk-1 expressing cells. In vitro differentiation of mouse embryonic stem cells (mESCs) to embryoid bodies (EBs) recapitulate several aspects of early embryonic development, including the formation of a subset of Flk-1 expressing cells. By day 4 of EB differentiation, mesodermal lineages with distinct lineage potentials can be identified based on the expression of the two surface markers Flk-1 and Pdgfra. Cells expressing Flk-1 alone (Flk-1⁺/Pdgfrα⁻) are enriched for haematoendothelial precursors, whereas double-positive cells (Flk-1⁺/Pdgfrα⁺) are enriched for primitive/cardiac mesodermal lineages.  We previously identified six uncharacterized genes (Riken) as potential regulators of haematoendothelial or cardiac lineages commitment, namely I830077J02Rik,C130074G19Rik,1500009L16Rik,D630003M21Rik,D430041D05Rik and A530016L24Rik. We generated homozygous knockouts (KOs) of each of these 6 genes and performed bulk RNA sequencing of WT cells and gene KOs is the two sorted populations (Flk-1⁺/Pdgfrα⁻ and Flk-1⁺/Pdgfrα+) at day 4 of embryoid body differentiation.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Nucleic Acid Extraction - Total RNA of WT and KO lines was extracted using ReliaPrep RNA Cell MiniPrep System (Promega, #Z6012) according to the manufacturer’s instructions.</sample_protocol><sample_protocol>Sequencing - The sequencing libraries were loaded on an Illumina HiSeq2500 sequencer according to the Illumina TruSeq Rapid v2 protocol, with a single-read 50 bp setting.</sample_protocol><sample_protocol>Library Construction - RNA-seq libraries were prepared according to Illumina TruSeq stranded mRNA protocol following manufacturer’s instructions, starting with 200 ng of total RNA.</sample_protocol><sample_protocol>Sample Collection - Embryoid bodies at D4 were harvested by spinning at 300 rpm for 5 min, washed twice with PBS and dissociated using StemPro Accutase (Invitrogen, #A1110501). After two washes using PBS supplemented with 10% of FBS, single cells were filtered through a 0.22 µM cell strainer and counted for downstream applications.  D4 dissociated EBs were incubated with 0.5 µg of Biotin anti-mouse CD309 (VEGFR2, Flk-1) antibody (Biolegend, #121904) and 1 µg of PE anti-mouse CD140a Antibody (Biolegend, #135905) for 1 X 106 cells in 100 µl of staining buffer (10% FBS in PBS). After an incubation of 30 minutes at 4°C and 3 washes with the staining buffer, 1 X 106 cells in 100 µl of staining buffer were incubated with the secondary antibody APC Streptavidin (Biolegend, 405207) for 15 minutes at 4°C, washed three times and resuspended in staining buffer. Cell sorting was performed using the BD FACSAria™ III Cell Sorter (BD Biosciences) and FACSAria™ II SORP.</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>Processed Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><data_protocol>Data Transformation - Illumina adapters and poly-A sequences were trimmed off the reads, which were aligned to the GRCm38 reference genome using HiSat2 (v2.1.0). If a sample was sequenced on more than one flowcell, files were mapped independently, then sorted and merged using SAMtools. After sorting the alignment on read-name, quantification was performed using HT-seq count (v 0.11.2). Non-CCDS genes and transcripts were removed and only CCDS and miRbase transcript were used in the annotation. Ensembl v96 was used for transcript/gene annotation.</data_protocol><omics_type>Metabolomics</omics_type><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><instrument_platform>Illumina HiSeq 2500</instrument_platform><study_type>RNA-seq of coding RNA</study_type><species>Mus musculus</species><pubmed_authors>Giulia Picco</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA-seq of mouse wild-type and I830077J02Rik,C130074G19Rik,1500009L16Rik,D630003M21Rik,D430041D05Rik and A530016L24Rik gene knockouts in Flk-1+/Pdgfra+ and Flk-1+/Pdgfra- sorted populations at day 4 of embryoid body differentiation</name><description>Haematopoietic and endothelial cells derive from a subset of Flk-1 expressing cells. In vitro differentiation of mouse embryonic stem cells (mESCs) to embryoid bodies (EBs) recapitulate several aspects of early embryonic development, including the formation of a subset of Flk-1 expressing cells. By day 4 of EB differentiation, mesodermal lineages with distinct lineage potentials can be identified based on the expression of the two surface markers Flk-1 and Pdgfra. Cells expressing Flk-1 alone (Flk-1⁺/Pdgfrα⁻) are enriched for haematoendothelial precursors, whereas double-positive cells (Flk-1⁺/Pdgfrα⁺) are enriched for primitive/cardiac mesodermal lineages.  We previously identified six uncharacterized genes (Riken) as potential regulators of haematoendothelial or cardiac lineages commitment, namely I830077J02Rik,C130074G19Rik,1500009L16Rik,D630003M21Rik,D430041D05Rik and A530016L24Rik. We generated homozygous knockouts (KOs) of each of these 6 genes and performed bulk RNA sequencing of WT cells and gene KOs is the two sorted populations (Flk-1⁺/Pdgfrα⁻ and Flk-1⁺/Pdgfrα+) at day 4 of embryoid body differentiation.</description><dates><release>2026-01-14T00:00:00Z</release><modification>2026-05-26T15:02:37.171Z</modification><creation>2025-09-12T13:21:21.434Z</creation></dates><accession>E-MTAB-15596</accession><cross_references><ENA>ERP180024</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003816</EFO><EFO>EFO_0003738</EFO><EFO>EFO_0004184</EFO></cross_references></HashMap>